Translational Development Acquisition Corp Units
TDACU
5 hedge funds and large institutions have $8.6M invested in Translational Development Acquisition Corp Units in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more ownership
Funds ownership: 5.38% → 5.38% (0%)
4% less capital invested
Capital invested by funds: $8.95M → $8.6M (-$355K)
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Calamos Advisors
Naperville,
Illinois
| $4.03M | – | – | – |
|
2
D.E. Shaw & Co
New York
| $3.69M | – | – | – |
|
|
YCM
3
Yakira Capital Management
Westport,
Connecticut
| $638K | – | – | – |
|
|
FTUS
4
Flow Traders U.S.
New York
| $148K | – | – | – |
|
5
UBS Group
Zurich,
Switzerland
| $87.6K | – | – | – |
|
TDACU Hedge Fund Activity: Q1 2026 in Review
5 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Translational Development Acquisition Corp Units (TDACU) for Q1 2026, worth a combined $8.6M — down 4% from $8.95M a quarter earlier.
Fund positioning in TDACU was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 5 institutional investors held Translational Development Acquisition Corp Units (TDACU) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $8.6M of Translational Development Acquisition Corp Units stock for Q1 2026, down 4% quarter-over-quarter.
- 0 funds opened new Translational Development Acquisition Corp Units positions in Q1 2026 and 0 closed out.
Based on aggregated 13F filings for Q1 2026.